NASDAQ

Personalis, Inc. (PSNL)

529 Thanks from members

Personalis, Inc. (PSNL) exhibits extremely bullish sentiment driven by an agreed acquisition by Tempus AI at $16.25 per share, impressive Q2 revenue beats, and surging NeXT Personal MRD test volumes, though tempered by widening net losses and legal challenges.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →